Introduction
Ossotide sodium chloride injection is a specialized pharmaceutical product designed to address a range of bone and joint conditions. Formulated with a combination of active peptides and sodium chloride, this injection offers a targeted approach to treating disorders such as osteoporosis, rheumatoid arthritis, and other proliferative bone diseases. Manufactured by Shijiazhuang Kunxiangda Technology Co., Ltd., the product is engineered to provide both therapeutic and supportive benefits to patients. This article provides an in-depth analysis of its features, applications, and the scientific principles behind its formulation.
Product Overview
Ossotide sodium chloride injection is a sterile, colorless to slightly yellow liquid solution designed for intravenous administration. Each 100ml vial contains 0.1g of Ossotide (a peptide substance) and 0.87g of sodium chloride. This formulation ensures precise dosing and compatibility with standard infusion protocols. The product is packaged in glass bottles, which are known for their stability and resistance to contamination, making them ideal for pharmaceutical use.
The active ingredient, Ossotide, is a synthetic peptide derived from bone metabolism-related compounds. When combined with sodium chloride, it creates a balanced solution that supports physiological functions while delivering therapeutic effects. The product is specifically indicated for patients with conditions such as rheumatoid arthritis, rheumatism, and bone fractures, where bone regeneration and inflammation control are critical.
Manufactured by Shijiazhuang Kunxiangda Technology Co., Ltd., this injection is produced under stringent quality control measures to ensure safety and efficacy. The company, based in Shijiazhuang, China, has established itself as a reliable provider of pharmaceutical solutions, emphasizing innovation and adherence to international standards.
Key Features and Advantages
One of the standout features of Ossotide sodium chloride injection is its dual-action mechanism. The peptide component stimulates osteoblast activity, promoting new bone formation, while sodium chloride maintains the solution's isotonicity, ensuring compatibility with the body's fluids. This synergy makes it an effective treatment for conditions like osteoporosis, where bone density is compromised.
Another advantage is its targeted delivery system. By administering the solution intravenously, the active ingredients bypass the digestive system, allowing for rapid absorption and systemic distribution. This method is particularly beneficial for patients who may have difficulty with oral medications or require immediate therapeutic effects.
The product also includes clear usage guidelines, which are crucial for safe administration. It is recommended for intravenous infusion at a dose of 50-100ml once daily, with a treatment course lasting 15-30 days. Healthcare professionals are advised to adjust the dosage based on individual patient needs and medical supervision.
Additionally, the product's shelf life of two years under proper storage conditions ensures long-term usability, reducing waste and cost for healthcare providers. The glass bottles used for packaging further enhance the product's stability, protecting it from light and external contaminants.
Technical Specifications
| Parameter | Details |
|---|---|
| Volume | 100ml |
| Ossotide Content | 0.1g |
| Sodium Chloride Content | 0.87g |
| Form | Colorless to slightly yellow clear liquid |
| Packaging | Glass infusion bottles (20 bottles/box) |
| Storage Conditions | Sealed, in a cool and shady place |
| Shelf Life | 2 years |
| Administration Route | Intravenous infusion |
Applications and Indications
Ossotide sodium chloride injection is primarily used to treat proliferative bone and joint diseases, including rheumatoid arthritis and rheumatism. Its ability to regulate bone metabolism and stimulate osteoblast proliferation makes it an effective solution for patients with conditions like osteoporosis. By enhancing calcium and phosphorus metabolism, the product helps increase bone calcium deposition, reducing the risk of fractures and improving overall bone strength.
The injection is also beneficial in post-fracture recovery. By promoting new bone formation and reducing inflammation, it accelerates the healing process, allowing patients to regain mobility more quickly. This makes it a valuable tool in orthopedic care and rehabilitation programs.
For patients with chronic inflammatory conditions, the product's anti-inflammatory and analgesic properties provide relief from pain and swelling. This dual action addresses both the symptoms and underlying causes of joint disorders, offering a comprehensive treatment approach.
Company Background: Shijiazhuang Kunxiangda Technology Co., Ltd.
Shijiazhuang Kunxiangda Technology Co., Ltd. is a reputable pharmaceutical company based in Shijiazhuang, China. With a focus on developing innovative medical solutions, the company has established a strong presence in the healthcare industry. Its commitment to quality and research has enabled it to produce products that meet international standards, ensuring safety and efficacy for patients.
The company's expertise in pharmaceutical formulation and production is reflected in the development of Ossotide sodium chloride injection. By leveraging advanced technologies and adhering to rigorous quality control protocols, Shijiazhuang Kunxiangda Technology Co., Ltd. ensures that its products are both reliable and effective. This dedication to excellence has earned the company recognition among healthcare professionals and patients alike.
Important Considerations and Precautions
While Ossotide sodium chloride injection offers numerous benefits, it is essential to follow the prescribed guidelines to avoid adverse effects. The product is contraindicated for individuals with severe renal insufficiency or known allergies to its components. Patients with a history of allergic reactions should use the injection with caution and under medical supervision.
Common adverse reactions include fever, rash, and decreased blood pressure. If any of these symptoms occur, patients should discontinue use and consult a healthcare provider immediately. Additionally, the solution should not be used if it appears turbid or discolored, as this may indicate contamination or degradation.
Pregnant and lactating women are advised against using the product, as its safety in these populations has not been fully established. Patients should also avoid combining the injection with amino acid drugs or alkaline medications, as these may interfere with its efficacy or cause adverse interactions.
Scientific and Medical Validation
The efficacy of Ossotide sodium chloride injection is supported by its pharmacological properties. According to the product's documentation, the active peptide component regulates bone metabolism by stimulating osteoblast proliferation and promoting new bone formation. This mechanism is critical for treating conditions like osteoporosis, where bone resorption outpaces bone formation.
Furthermore, the product's ability to regulate calcium and phosphorus metabolism enhances bone calcium deposition, which is essential for maintaining bone density. These effects are complemented by its anti-inflammatory and analgesic properties, which help alleviate pain and swelling associated with joint disorders.
While the product's claims are based on internal research, the principles underlying its formulation align with broader scientific understanding of bone health. For instance, the National Institute of Standards and Technology (NIST) emphasizes the importance of precise measurements in pharmaceutical development, ensuring that products like Ossotide sodium chloride injection meet rigorous quality standards [1].
Conclusion
Ossotide sodium chloride injection represents a significant advancement in the treatment of bone and joint disorders. Its unique formulation, combining active peptides with sodium chloride, offers a dual approach to addressing both the structural and inflammatory aspects of these conditions. With clear usage guidelines, a long shelf life, and a focus on safety, the product is a valuable addition to modern medical practices.
Manufactured by Shijiazhuang Kunxiangda Technology Co., Ltd., the injection reflects the company's commitment to innovation and quality. As research in bone metabolism continues to evolve, products like Ossotide sodium chloride injection will play a vital role in improving patient outcomes and quality of life.
References
[1] National Institute of Standards and Technology (NIST)
For further information about the scientific principles behind pharmaceutical formulations, visit the NIST website to explore their research on measurement standards and quality control in healthcare.